{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:41:07Z","timestamp":1791582067041,"version":"4.3.4"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100009018","name":"Shanghai Municipal Human Resources and Social Security Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.cmi.2019.07.010","type":"journal-article","created":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T11:36:37Z","timestamp":1562931397000},"page":"313-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["How does Pseudomonas aeruginosa affect the progression of bronchiectasis?"],"prefix":"10.1016","volume":"26","author":[{"given":"Y.-H.","family":"Chai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-F.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.07.010_bib1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1513\/AnnalsATS.201511-740PS","article-title":"Bronchiectasis in China","volume":"13","author":"Lin","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.cmi.2019.07.010_bib2","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1164\/rccm.201210-1937OC","article-title":"Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation","volume":"187","author":"Tunney","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2019.07.010_bib3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1183\/09031936.00003709","article-title":"Mortality in bronchiectasis: a long-term study assessing the factors influencing survival","volume":"34","author":"Loebinger","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2019.07.010_bib4","article-title":"Pseudomonas aeruginosa isolation in patients with non\u2013cystic fibrosis bronchiectasis: a retrospective study","volume":"8","author":"Wang","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.cmi.2019.07.010_bib5","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1183\/09031936.00026313","article-title":"Multidimensional approach to non\u2013cystic fibrosis bronchiectasis: the FACED score","volume":"43","author":"Mart\u00ednez-Garc\u00eda","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2019.07.010_bib6","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The Bronchiectasis Severity Index. An international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2019.07.010_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/COPD.S121943","article-title":"Predicting high risk of exacerbations in bronchiectasis: the E-FACED score","volume":"12","author":"Mart\u00ednez-Garc\u00eda","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.cmi.2019.07.010_bib8","first-page":"1602","article-title":"A\u00a0comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis","volume":"12","author":"Finch","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.cmi.2019.07.010_bib9","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1183\/09031936.06.00074605","article-title":"The effect of Pseudomonas aeruginosa on pulmonary function in patients with bronchiectasis","volume":"28","author":"Davies","year":"2006","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2019.07.010_bib10","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1183\/13993003.01862-2015","article-title":"Asthma and bronchiectasis exacerbation","volume":"47","author":"Mao","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2019.07.010_bib11","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/resp.12768","article-title":"Factors associated with radiologic progression of non\u2013cystic fibrosis bronchiectasis during long-term follow-up","volume":"21","author":"Park","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.cmi.2019.07.010_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2016.05.001","article-title":"Non CF-bronchiectasis: aetiologic approach, clinical, radiological, microbiological and functional profile in 277 patients","volume":"116","author":"Dimakou","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.cmi.2019.07.010_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111913","article-title":"Characterizing non-tuberculous mycobacteria infection in bronchiectasis","volume":"17","author":"Faverio","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cmi.2019.07.010_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.rmed.2014.07.021","article-title":"Non cystic fibrosis bronchiectasis: a longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance","volume":"109","author":"McDonnell","year":"2015","journal-title":"Respir Med"},{"key":"10.1016\/j.cmi.2019.07.010_bib15","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1183\/13993003.01899-2015","article-title":"Clinical phenotypes in adult patients with bronchiectasis","volume":"47","author":"Aliberti","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2019.07.010_bib16","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1378\/chest.07-0490","article-title":"Factors associated with lung function decline in adult patients with stable non\u2013cystic fibrosis bronchiectasis","volume":"132","author":"Mart\u00ednez-Garc\u00eda","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.cmi.2019.07.010_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01953-2017","article-title":"The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasislong-term clinical outcomes in bronchiectasis","volume":"51","author":"Ara\u00fajo","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2019.07.010_bib18","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2147\/COPD.S150250","article-title":"Antibiotic-resistant Pseudomonas aeruginosa infection in patients with bronchiectasis: prevalence, risk factors and prognostic implications","volume":"13","author":"Gao","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.cmi.2019.07.010_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/ppul.21526","article-title":"Lung function decline from adolescence to young adulthood in cystic fibrosis","volume":"47","author":"Vandenbranden","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.cmi.2019.07.010_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000087686","article-title":"Outcomes of adults with cystic fibrosis infected with antibiotic-resistant Pseudomonas aeruginosa","volume":"73","author":"Lechtzin","year":"2006","journal-title":"Respiration"},{"key":"10.1016\/j.cmi.2019.07.010_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.tim.2016.01.008","article-title":"Pseudomonas aeruginosa evolutionary adaptation and diversification in cystic fibrosis chronic lung infections","volume":"24","author":"Winstanley","year":"2016","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.cmi.2019.07.010_bib22","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.4049\/jimmunol.1501642","article-title":"Clinical isolates of Pseudomonas aeruginosa from chronically infected cystic fibrosis patients fail to activate the inflammasome during both stable infection and pulmonary exacerbation","volume":"196","author":"Huus","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2019.07.010_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1164\/rccm.201404-0681OC","article-title":"Pseudomonas aeruginosa in\u00a0vitro phenotypes distinguish cystic fibrosis infection stages and outcomes","volume":"190","author":"Mayer-Hamblett","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2019.07.010_bib24","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1186\/s12864-015-2069-0","article-title":"Genotypic and phenotypic analyses of a Pseudomonas aeruginosa chronic bronchiectasis isolate reveal differences from cystic fibrosis and laboratory strains","volume":"16","author":"Varga","year":"2015","journal-title":"BMC Genomics"},{"key":"10.1016\/j.cmi.2019.07.010_bib25","first-page":"1697","article-title":"Macrolide treatment inhibits Pseudomonas aeruginosa quorum sensing in non\u2013cystic fibrosis bronchiectasis. An analysis from the Bronchiectasis and Low-Dose Erythromycin Study trial","volume":"13","author":"Burr","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.cmi.2019.07.010_bib26","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/AAC.48.9.3457-3461.2004","article-title":"Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-oxododecanoyl) homoserine lactone in NCI-H292 cells","volume":"48","author":"Imamura","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.07.010_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1073\/pnas.1617415113","article-title":"Quorum sensing controls the Pseudomonas aeruginosa CRISPR-Cas adaptive immune system","volume":"114","author":"Hoyland-Kroghsbo","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cmi.2019.07.010_bib28","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41564-018-0290-8","article-title":"Pseudomonas aeruginosa quorum-sensing metabolite induces host immune cell death through cell surface lipid domain dissolution","volume":"4","author":"Song","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.cmi.2019.07.010_bib29","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.1039\/C8SC02496K","article-title":"Disarming the virulence arsenal of Pseudomonas aeruginosa by blocking two-component system signaling","volume":"9","author":"Goswami","year":"2018","journal-title":"Chem Sci"},{"key":"10.1016\/j.cmi.2019.07.010_bib30","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/35023079","article-title":"Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen","volume":"406","author":"Stover","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cmi.2019.07.010_bib31","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1128\/AAC.49.8.3382-3386.2005","article-title":"Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections","volume":"49","author":"Macia","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.07.010_bib32","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1128\/AAC.00148-07","article-title":"Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation","volume":"51","author":"Henrichfreise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2019.07.010_bib33","doi-asserted-by":"crossref","first-page":"20747","DOI":"10.1073\/pnas.1221552110","article-title":"Enhanced in\u00a0vivo fitness of carbapenem-resistant oprD mutants of Pseudomonas aeruginosa revealed through high-throughput sequencing","volume":"110","author":"Skurnik","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cmi.2019.07.010_bib34","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00517-17","article-title":"Evolved aztreonam resistance is multifactorial and can produce hypervirulence in Pseudomonas aeruginosa","volume":"8","author":"Jorth","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.cmi.2019.07.010_bib35","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1469-0691.2007.01939.x","article-title":"Comparison of type III secretion system virulence among fluoroquinolone-susceptible and -resistant clinical isolates of Pseudomonas aeruginosa","volume":"14","author":"Wong-Beringer","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.07.010_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042973","article-title":"Differentiation in quinolone resistance by virulence genotype in Pseudomonas aeruginosa","volume":"7","author":"Agnello","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.07.010_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/CCM.0b013e318298a86f","article-title":"Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa","volume":"42","author":"Sullivan","year":"2014","journal-title":"Crit Care Med"},{"key":"10.1016\/j.cmi.2019.07.010_bib38","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.cmi.2018.07.008","article-title":"Presence of pldA and exoU in mucoid Pseudomonas aeruginosa is associated with high risk of exacerbations in non\u2013cystic fibrosis bronchiectasis patients","volume":"25","author":"Luo","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2019.07.010_bib39","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S2213-2600(15)00228-3","article-title":"The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis","volume":"3","author":"Kidd","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.cmi.2019.07.010_bib40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1136\/thorax.57.6.559","article-title":"Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives","volume":"57","author":"McCallum","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2019.07.010_bib41","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000438490","article-title":"Eradication therapy against Pseudomonas aeruginosa in non\u2013cystic fibrosis bronchiectasis","volume":"90","author":"Orriols","year":"2015","journal-title":"Respiration"},{"key":"10.1016\/j.cmi.2019.07.010_bib42","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.rmed.2011.11.018","article-title":"Outcomes of Pseudomonas eradication therapy in patients with non\u2013cystic fibrosis bronchiectasis","volume":"106","author":"White","year":"2012","journal-title":"Respir Med"},{"issue":"Suppl 1","key":"10.1016\/j.cmi.2019.07.010_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British Thoracic Society guideline for bronchiectasis in adults","volume":"74","author":"Hill","year":"2019","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2019.07.010_bib44","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2019.07.010_bib45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1183\/09031936.00122508","article-title":"Assessing response to treatment of exacerbations of bronchiectasis in adults","volume":"33","author":"Murray","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2019.07.010_bib46","doi-asserted-by":"crossref","first-page":"L677","DOI":"10.1152\/ajplung.00123.2017","article-title":"Macrolides protect against Pseudomonas aeruginosa infection via inhibition of inflammasomes","volume":"313","author":"Fan","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.cmi.2019.07.010_bib47","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/thoraxjnl-2016-209265","article-title":"Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa","volume":"72","author":"Waters","year":"2017","journal-title":"Thorax"},{"key":"10.1016\/j.cmi.2019.07.010_bib48","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/stem.1996","article-title":"Adipose tissue\u2013derived mesenchymal stem cells attenuate pulmonary infection caused by Pseudomonas aeruginosa via inhibiting overproduction of prostaglandin E2","volume":"33","author":"Mao","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.cmi.2019.07.010_bib49","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1034\/j.1399-3003.2000.16a26.x","article-title":"Endothelin-1 in stable bronchiectasis","volume":"16","author":"Zheng","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2019.07.010_bib50","first-page":"130","article-title":"[Pulmonary function and quality of life in relation to bronchial colonization in adults with bronchiectasis not caused by cystic fibrosis]","volume":"118","author":"Hernandez","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.cmi.2019.07.010_bib51","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ejim.2003.10.002","article-title":"Bronchiectasis in secondary care: a comprehensive profile of a neglected disease","volume":"14","author":"Kelly","year":"2003","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.cmi.2019.07.010_bib52","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.rmed.2007.03.009","article-title":"Microbiologic follow-up study in adult bronchiectasis","volume":"101","author":"King","year":"2007","journal-title":"Respir Med"},{"key":"10.1016\/j.cmi.2019.07.010_bib53","doi-asserted-by":"crossref","first-page":"340","DOI":"10.5578\/tt.2934","article-title":"Does airway colonization cause systemic inflammation in bronchiectasis?","volume":"59","author":"Ergan Arsava","year":"2011","journal-title":"Tuberk Toraks"},{"key":"10.1016\/j.cmi.2019.07.010_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1465-9921-13-21","article-title":"Risk factors for morbidity and death in non\u2013cystic fibrosis bronchiectasis: a retrospective cross-sectional analysis of CT diagnosed bronchiectatic patients","volume":"13","author":"Goeminne","year":"2012","journal-title":"Respir Res"},{"key":"10.1016\/j.cmi.2019.07.010_bib55","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/qjmed\/hcr184","article-title":"Fatigue in bronchiectasis","volume":"105","author":"Hester","year":"2012","journal-title":"QJM"},{"key":"10.1016\/j.cmi.2019.07.010_bib56","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1513\/AnnalsATS.201310-335OC","article-title":"A\u00a0novel microbiota stratification system predicts future exacerbations in bronchiectasis","volume":"11","author":"Rogers","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.cmi.2019.07.010_bib57","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.rmed.2013.12.015","article-title":"Mortality in non\u2013cystic fibrosis bronchiectasis: a prospective cohort analysis","volume":"108","author":"Goeminne","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.cmi.2019.07.010_bib58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/ppul.10380","article-title":"Pseudomonas aeruginosa and cystic fibrosis: correlation between exoenzyme production and patient\u2019s clinical state","volume":"36","author":"Lanotte","year":"2003","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.cmi.2019.07.010_bib59","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.4049\/jimmunol.173.9.5659","article-title":"Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease","volume":"173","author":"Cobb","year":"2004","journal-title":"J\u00a0Immunol"},{"issue":"Pt 12","key":"10.1016\/j.cmi.2019.07.010_bib60","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1099\/jmm.0.46845-0","article-title":"Protease IV production in Pseudomonas aeruginosa from the lungs of adults with cystic fibrosis","volume":"55","author":"Smith","year":"2006","journal-title":"J\u00a0Med Microbiol"},{"key":"10.1016\/j.cmi.2019.07.010_bib61","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1183\/09031936.00159607","article-title":"Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients","volume":"32","author":"Ryall","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cmi.2019.07.010_bib62","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1164\/rccm.201009-1430OC","article-title":"Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections","volume":"183","author":"Mowat","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cmi.2019.07.010_bib63","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.4049\/jimmunol.1202144","article-title":"Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease","volume":"190","author":"Rieber","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2019.07.010_bib64","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jcf.2012.08.001","article-title":"Pseudomonas aeruginosa serology and risk for re-isolation in the EPIC trial","volume":"12","author":"Anstead","year":"2013","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.cmi.2019.07.010_bib65","first-page":"227","article-title":"Type IV pilus of Pseudomonas aeruginosa confers resistance to antimicrobial activities of the pulmonary surfactant protein-A","volume":"6","author":"Tan","year":"2014","journal-title":"J\u00a0Innate Immun"},{"key":"10.1016\/j.cmi.2019.07.010_bib66","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1128\/IAI.00098-16","article-title":"Role of iron uptake systems in Pseudomonas aeruginosa virulence and airway infection","volume":"84","author":"Minandri","year":"2016","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2019.07.010_bib67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/thoraxjnl-2017-210298","article-title":"Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator\u2013IL-6\u2013antimicrobial-repair pathway","volume":"73","author":"Saint-Criq","year":"2018","journal-title":"Thorax"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19303994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19303994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:23:45Z","timestamp":1761117825000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19303994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1198743X19303994"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.07.010","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How does Pseudomonas aeruginosa affect the progression of bronchiectasis?","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}